10x Insights
Loading account…
Companies / Financials / SkyAI, Inc.
SKYA

SkyAI, Inc.

FinancialsFinance Services
Ticker SKYAMELVILLE, NYFiscal year ends DecemberBook value per share $2.17Diluted shares 72.3M

Sharps Technology, Inc. (NASDAQ: STSS) operates as a medical device sales and distribution enterprise with a strategic pivot toward digital asset treasury management. The company's website is located at www.sharpstechnology.com. From the company’s description.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$0.20M
Last 12 mo $0.17M
-132145.49%
Last 12 mo -214930.87%
$-270.34M
−2808.0% year over year
Last 12 mo $-385.34M
-106.85%
+358.9 percentage points
Last 12 mo -252.74%
Cash & financing
$-10.99M
−58.6% year over year
Last 12 mo $-12.31M
$-10.99M
−55.0% year over year
Last 12 mo $-12.31M
0.01
Was 1.94× a year earlier
Last 12 mo 0.00
25.3M
+1914.4% year over year
Last 12 mo 72.3M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What SkyAI, Inc. does

In the company’s own words

Sharps Technology, Inc. (NASDAQ: STSS) operates as a medical device sales and distribution enterprise with a strategic pivot toward digital asset treasury management. The company's website is located at www.sharpstechnology.com.

Historically, Sharps Technology focused on the marketing and distribution of syringe products and related drug-delivery systems, including conventional and safety syringes for clinical, pharmaceutical, and specialty applications. The company previously designed and manufactured these products for hospitals, clinics, healthcare providers, and medical supply organizations across domestic and international markets. While the company continues to market certain remaining inventory from its legacy operations, this traditional medical device business now represents a diminished portion of its strategic focus.

In August 2025, Sharps Technology adopted a comprehensive digital asset treasury strategy centered on accumulating Solana (SOL), the native digital asset of the Solana blockchain. Following the closing of a private investment in public equity offering of approximately $400 million in August 2025, the company purchased and holds over two million SOL tokens, representing the vast majority of capital raised in that offering. The company also maintains holdings in USDC and USDT stablecoins as part of its treasury composition.

The company's treasury strategy emphasizes long-term exposure to SOL through multiple mechanisms, including staking rewards, potential price appreciation, and selective use of derivative instruments for risk management. The company delegates SOL to diversified validators and liquid staking protocols while maintaining custody through qualified third-party custodians including BitGo, Anchorage Digital Bank, and Coinbase. The company has established a Treasury Oversight Committee to manage implementation of its treasury policy and has engaged consulting and strategic advisory services related to its digital asset operations.

Beyond its core treasury strategy and legacy medical device distribution, Sharps Technology has begun exploring strategic acquisitions and investments globally, with treasury and engineering teams analyzing opportunities and developing digital products. The company maintains compliance with applicable regulatory and quality standards governing medical device distribution, including FDA requirements and international authorities' standards.

Company details
Sector
Financials
Industry
Finance Services
Headquarters
MELVILLE, NY
Fiscal year end
December
CIK
1737995
SIC
6199

Financial performance, year by year

Fiscal 2022–2025 · USD
$-423.90M$-308.23M$-192.57M$-76.91M$38.76M2022202320242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns SkyAI, Inc. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

12
funds hold it
0 of 35
superinvestors hold it
$3.07M
held by funds, at market
5.3%
of shares held by funds

Largest fund holders · SkyAI, Inc.’s weight in each

VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
VANGUARD EXTENDED MARKET INDEX FUND
VXF · VANGUARD INDEX FUNDS
0.00%of fund net assets
Fidelity Extended Market Index Fund
FSMAX · Fidelity Concord Street Trust
0.00%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Could not be determined for this company: bond issues.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do SkyAI, Inc. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of SkyAI, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in SkyAI, Inc.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.